The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice

Respiratory Research

Volumn 9, Issue , 2008, Pages

  Tate, Michelle D ^a   Brooks, Andrew G ^a   Reading, Patrick C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; C57BL MOUSE; CD8+ T LYMPHOCYTE; DISEASE MODEL; DRUG EFFECT; INFLUENZA VIRUS A; MALE; MOUSE; MOUSE MUTANT; NEUTROPENIA; NEUTROPHIL; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; RESPIRATORY SYSTEM; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; INFLUENZA A VIRUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPENIA; NEUTROPHILS; ORTHOMYXOVIRIDAE INFECTIONS; PHENOTYPE; RESPIRATORY SYSTEM;

EID: 52649136695     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-9-57     Document Type: Article

References (49)

1. Hennet T, Ziltener HJ, Frei K, Peterhans E. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 1992, 149(3):932-939.
2. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunological reviews 1997, 159:105-117. 10.1111/j.1600-065X.1997.tb01010.x, 9416506.
3. Sweet C, Smith H. Pathogenicity of influenza virus. Microbiological reviews 1980, 44(2):303-330. 373180, 6991901.
4. Fujisawa H, Tsuru S, Taniguchi M, Zinnaka Y, Nomoto K. Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection. The Journal of general virology 1987, 68(Pt 2):425-432. 10.1099/0022-1317-68-2-425, 3819696.
5. Fujisawa H. Inhibitory role of neutrophils on influenza virus multiplication in the lungs of mice. Microbiol Immunol 2001, 45(10):679-688.
6. Fujisawa H. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. Journal of virology 2008, 82(6):2772-2783. 2258992, 18184718, 10.1128/JVI.01210-07.
7. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM, et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. Journal of virology 2005, 79(23):14933-14944. 1287592, 16282492, 10.1128/JVI.79.23.14933-14944.2005.
8. de Oca RM, Buendia AJ, Del Rio L, Sanchez J, Salinas J, Navarro JA. Polymorphonuclear neutrophils are necessary for the recruitment of CD8(+) T cells in the liver in a pregnant mouse model of Chlamydophila abortus (Chlamydia psittaci serotype 1) infection. Infection and immunity 2000, 68(3):1746-1751.
9. Matsuzaki J, Tsuji T, Chamoto K, Takeshima T, Sendo F, Nishimura T. Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo. Cellular immunology 2003, 224(2):98-105. 10.1016/j.cellimm.2003.08.009, 14609575.
10. Tumpey TM, Chen SH, Oakes JE, Lausch RN. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. Journal of virology 1996, 70(2):898-904. 189893, 8551629.
11. Zhou J, Stohlman SA, Hinton DR, Marten NW. Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J Immunol 2003, 170(6):3331-3336.
12. Reading PC, Morey LS, Crouch EC, Anders EM. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. Journal of virology 1997, 71(11):8204-8212. 192277, 9343171.
13. Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 1992, 71(7):1205-1214. 10.1016/S0092-8674(05)80068-6, 1473153.
14. Baez M, Palese P, Kilbourne ED. Gene composition of high-yielding influenza vaccine strains obtained by recombination. The Journal of infectious diseases 1980, 141(3):362-365.
15. Anders EM, Hartley CA, Jackson DC. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proceedings of the National Academy of Sciences of the United States of America 1990, 87(12):4485-4489. 54140, 2162043, 10.1073/pnas.87.12.4485.
16. Fleming TJ, Fleming ML, Malek TR. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J Immunol 1993, 151(5):2399-2408.
17. Tepper RI, Coffman RL, Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992, 257(5069):548-551. 10.1126/science.1636093, 1636093.
18. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984, 312(5994):548-551. 10.1038/312548a0, 6150440.
19. Lawrence BP, Meyer M, Reed DJ, Kerkvliet NI. Role of glutathione and reactive oxygen intermediates in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immune suppression in C57Bl/6 mice. Toxicol Sci 1999, 52(1):50-60. 10.1093/toxsci/52.1.50, 10568698.
20. Teske S, Bohn AA, Regal JF, Neumiller JJ, Lawrence BP. Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza A virus. American journal of physiology 2005, 289(1):L111-124.
21. Atzeni F, Schena M, Ongari AM, Carrabba M, Bonara P, Minonzio F, Capsoni F. Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-gamma, and IFN-alpha. Cellular immunology 2002, 220(1):20-29. 10.1016/S0008-8749(03)00002-9, 12718936.
22. Dahlgren C, Carlsson SR, Karlsson A, Lundqvist H, Sjolin C. The lysosomal membrane glycoproteins Lamp-1 and Lamp-2 are present in mobilizable organelles, but are absent from the azurophil granules of human neutrophils. The Biochemical journal 1995, 311(Pt 2):667-674. 1136051, 7487911.
23. Hartshorn KL, Karnad AB, Tauber AI. Influenza A virus and the neutrophil: a model of natural immunity. Journal of leukocyte biology 1990, 47(2):176-186.
24. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 1983, 130(4):1910-1917.
25. Asselin-Paturel C, Brizard G, Pin JJ, Briere F, Trinchieri G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 2003, 171(12):6466-6477.
26. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezutter-Dambuyant C, Vicari A, O'Garra A, Biron C, Briere F, et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nature immunology 2001, 2(12):1144-1150. 10.1038/ni736, 11713464.
27. Czuprynski CJ, Brown JF, Maroushek N, Wagner RD, Steinberg H. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol 1994, 152(4):1836-1846.
28. Han Y, Cutler JE. Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. The Journal of infectious diseases 1997, 175(5):1169-1175.
29. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. Journal of leukocyte biology 2008, 83(1):64-70. 10.1189/jlb.0407247, 17884993.
30. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19(1):71-82. 10.1016/S1074-7613(03)00174-2, 12871640.
31. Sunderkotter C, Nikolic T, Dillon MJ, Van Rooijen N, Stehling M, Drevets DA, Leenen PJ. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 2004, 172(7):4410-4417.
32. Guo RF, Ward PA. Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free radical biology & medicine 2002, 33(3):303-310. 10.1016/S0891-5849(02)00823-7, 12126752.
33. Ratcliffe DR, Nolin SL, Cramer EB. Neutrophil interaction with influenza-infected epithelial cells. Blood 1988, 72(1):142-149.
34. Hashimoto Y, Moki T, Takizawa T, Shiratsuchi A, Nakanishi Y. Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol 2007, 178(4):2448-2457.
35. Daher KA, Selsted ME, Lehrer RI. Direct inactivation of viruses by human granulocyte defensins. Journal of virology 1986, 60(3):1068-1074. 253347, 3023659.
36. Hartshorn KL, White MR, Tecle T, Holmskov U, Crouch EC. Innate defense against influenza A virus: activity of human neutrophil defensins and interactions of defensins with surfactant protein D. J Immunol 2006, 176(11):6962-6972.
37. Jaillon S, Peri G, Delneste Y, Fremaux I, Doni A, Moalli F, Garlanda C, Romani L, Gascan H, Bellocchio S, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. The Journal of experimental medicine 2007, 204(4):793-804. 2118544, 17389238, 10.1084/jem.20061301.
38. Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, Job ER, Crouch EC, Brooks AG, Brown LE, Bottazzi B, et al. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol 2008, 180(5):3391-3398.
39. Vacheron F, Rudent A, Perin S, Labarre C, Quero AM, Guenounou M. Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus. The Journal of general virology 1990, 71(Pt 2):477-479. 10.1099/0022-1317-71-2-477, 2137872.
40. Nagendra S, Schlueter AJ. Absence of cross-reactivity between murine Ly-6C and Ly-6G. Cytometry A 2004, 58(2):195-200. 10.1002/cyto.a.20007, 15057973.
41. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon S, Guan Y, Peiris JS. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 2002, 360(9348):1831-1837. 10.1016/S0140-6736(02)11772-7, 12480361.
42. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nature medicine 2006, 12(10):1203-1207. 10.1038/nm1477, 16964257.
43. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, Hatta Y, Kim JH, Halfmann P, Hatta M, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007, 445(7125):319-323. 10.1038/nature05495, 17230189.
44. Mbawuike IN, Zhang Y, Couch RB. Control of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytes. Respiratory research 2007, 8:44. 1914056, 17597533, 10.1186/1465-9921-8-44.
45. Wiley JA, Hogan RJ, Woodland DL, Harmsen AG. Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection. J Immunol 2001, 167(6):3293-3299.
46. Wiley JA, Tighe MP, Harmsen AG. Upper respiratory tract resistance to influenza infection is not prevented by the absence of either nasal-associated lymphoid tissue or cervical lymph nodes. J Immunol 2005, 175(5):3186-3196.
47. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966, 122(3):800-804.
48. Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, Nguyen T, Lien PS, Le QM, Kawaoka Y. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS pathogens 2007, 3(10):1374-1379. 2000968, 17922570, 10.1371/journal.ppat.0030133.
49. Barchet W, Cella M, Odermatt B, Asselin-Paturel C, Colonna M, Kalinke U. Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. The Journal of experimental medicine 2002, 195(4):507-516. 2193622, 11854363, 10.1084/jem.20011666.